Compile Data Set for Download or QSAR
Report error Found 18 Enz. Inhib. hit(s) with all data for entry = 3282
TargetCatenin beta-1(Human)
Samumed

US Patent
LigandPNGBDBM396286(US10314832, Compound 2)
Affinity DataIC50: 13nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of ca...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
Go to US Patent

TargetCatenin beta-1(Human)
Samumed

US Patent
LigandPNGBDBM396284(US10314832, Compound 1)
Affinity DataIC50: 28.5nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of ca...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
Go to US Patent

TargetCatenin beta-1(Human)
Samumed

US Patent
LigandPNGBDBM396287(US10314832, Compound 3)
Affinity DataIC50: 38.5nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of ca...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
Go to US Patent

TargetCatenin beta-1(Human)
Samumed

US Patent
LigandPNGBDBM396292(US10314832, Compound 8)
Affinity DataIC50: 83nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of ca...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
Go to US Patent

TargetCatenin beta-1(Human)
Samumed

US Patent
LigandPNGBDBM396291(US10314832, Compound 7)
Affinity DataIC50: 183nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of ca...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
Go to US Patent

TargetCatenin beta-1(Human)
Samumed

US Patent
LigandPNGBDBM396288(US10314832, Compound 11 | US10314832, Compound 4)
Affinity DataIC50: 805nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of ca...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
Go to US Patent

TargetCatenin beta-1(Human)
Samumed

US Patent
LigandPNGBDBM396289(US10314832, Compound 5)
Affinity DataIC50: 1.27E+3nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of ca...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
Go to US Patent

TargetCatenin beta-1(Human)
Samumed

US Patent
LigandPNGBDBM396298(US10314832, Compound 15)
Affinity DataIC50: 1.39E+3nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of ca...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
Go to US Patent

TargetCatenin beta-1(Human)
Samumed

US Patent
LigandPNGBDBM396290(US10314832, Compound 6)
Affinity DataIC50: 2.10E+3nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of ca...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
Go to US Patent

TargetCatenin beta-1(Human)
Samumed

US Patent
LigandPNGBDBM396299(US10314832, Compound 16)
Affinity DataIC50: 2.57E+3nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of ca...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
Go to US Patent

TargetCatenin beta-1(Human)
Samumed

US Patent
LigandPNGBDBM396302(US10314832, Compound 19)
Affinity DataIC50: 3.90E+3nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of ca...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
Go to US Patent

TargetCatenin beta-1(Human)
Samumed

US Patent
LigandPNGBDBM396301(US10314832, Compound 18)
Affinity DataIC50: 6.00E+3nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of ca...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
Go to US Patent

TargetCatenin beta-1(Human)
Samumed

US Patent
LigandPNGBDBM396296(US10314832, Compound 12)
Affinity DataIC50: 1.00E+4nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of ca...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
Go to US Patent

TargetCatenin beta-1(Human)
Samumed

US Patent
LigandPNGBDBM396297(US10314832, Compound 14)
Affinity DataIC50: 1.00E+4nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of ca...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
Go to US Patent

TargetCatenin beta-1(Human)
Samumed

US Patent
LigandPNGBDBM396288(US10314832, Compound 11 | US10314832, Compound 4)
Affinity DataIC50: 1.00E+4nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of ca...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
Go to US Patent

TargetCatenin beta-1(Human)
Samumed

US Patent
LigandPNGBDBM396294(US10314832, Compound 10)
Affinity DataIC50: 1.00E+4nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of ca...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
Go to US Patent

TargetCatenin beta-1(Human)
Samumed

US Patent
LigandPNGBDBM396300(US10314832, Compound 17)
Affinity DataIC50: 1.00E+4nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of ca...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
Go to US Patent

TargetCatenin beta-1(Human)
Samumed

US Patent
LigandPNGBDBM396293(US10314832, Compound 9)
Affinity DataIC50: 1.00E+4nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of ca...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
Go to US Patent